PGG inhibited STAT3 Tyr705 phosphorylation in the prostate cancer DU145 cell line, thereby downregulating STAT3 transcriptional targets, such as Bcl-XL and Mcl-1, which decreased cell viability and increased caspase-mediated apoptosis. Here, BCL2L1 is linked to prostate carcinoma.